HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410
- PMID: 7908535
- PMCID: PMC504742
- DOI: 10.1136/bjo.78.3.223
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410
Abstract
Vogt-Koyanagi-Harada's (VKH) disease is reported to be closely associated with the HLA class II antigen, HLA-DR4. Serologically defined DR4 is further divided into 11 alleles by molecular HLA genotyping. However, no study of HLA-DNA typing of VKH patients has been reported. To clarify molecular genetic mechanism underlying the susceptibility/resistance to VKH disease, HLA-DNA typing of DR antigens (DRB1 genotyping) by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed. It was found that DRB1*0405 showed a significant association with VKH disease compared with the healthy controls (corrected p value < 1 x 10(-5)) and that all the patients had DRB1*0405 and/or DRB1*0410. The specific amino acid residue shared only by these two alleles is Ser at position 57 which is located in the antigen binding groove and may influence the immunological function as an antigen-presenting molecule, suggesting that Ser at position 57 plays an important role in the susceptibility to VKH disease, although the possibility that the involvement of the HLA-DQ molecule, DQ4, in strong linkage disequilibrium with DRB1*0405 and DRB1*0410, cannot be excluded.
Similar articles
-
Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease.Hum Immunol. 1994 Mar;39(3):169-76. doi: 10.1016/0198-8859(94)90257-7. Hum Immunol. 1994. PMID: 8026985
-
[The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].Zhonghua Yan Ke Za Zhi. 1997 Jul;33(4):268-71. Zhonghua Yan Ke Za Zhi. 1997. PMID: 10451958 Chinese.
-
Clinical and immunogenetic investigation of a Laotian patient with Vogt-Koyanagi-Harada's disease.Ophthalmologica. 1996;210(2):112-4. doi: 10.1159/000310685. Ophthalmologica. 1996. PMID: 9148256
-
Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.Sci Rep. 2014 Nov 10;4:6887. doi: 10.1038/srep06887. Sci Rep. 2014. PMID: 25382027 Free PMC article.
-
Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry.Aust N Z J Ophthalmol. 1996 May;24(2):147-9. doi: 10.1111/j.1442-9071.1996.tb01570.x. Aust N Z J Ophthalmol. 1996. PMID: 9199747 Review.
Cited by
-
Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.PLoS One. 2019 Aug 14;14(8):e0220858. doi: 10.1371/journal.pone.0220858. eCollection 2019. PLoS One. 2019. PMID: 31412073 Free PMC article.
-
Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.J Ophthalmic Inflamm Infect. 2022 May 12;12(1):17. doi: 10.1186/s12348-022-00293-3. J Ophthalmic Inflamm Infect. 2022. PMID: 35553272 Free PMC article. Review.
-
A COVID-19 perspective of Vogt-Koyanagi-Harada disease.Indian J Ophthalmol. 2023 Jun;71(6):2587-2591. doi: 10.4103/IJO.IJO_172_23. Indian J Ophthalmol. 2023. PMID: 37322685 Free PMC article.
-
Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.Intern Med. 2021 Nov 15;60(22):3593-3598. doi: 10.2169/internalmedicine.6410-20. Epub 2021 Jun 5. Intern Med. 2021. PMID: 34092725 Free PMC article.
-
Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease.Int Ophthalmol. 2007 Apr-Jun;27(2-3):87-95. doi: 10.1007/s10792-006-9020-y. Epub 2007 Jan 26. Int Ophthalmol. 2007. PMID: 17253112
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials